rosiglitazone has been researched along with Bile Duct Obstruction, Intrahepatic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Duan, Y; Guo, F; Hajjar, DP; Han, J; Hu, H; Hu, W; Kong, D; Li, Q; Li, X; Ma, C; Miao, QR; Wang, H; Wei, Z; Yang, X; Yu, M; Zhang, S; Zhang, Y; Zhu, Y | 1 |
| Moseley, RH; Snow, KL | 1 |
2 other study(ies) available for rosiglitazone and Bile Duct Obstruction, Intrahepatic
| Article | Year |
|---|---|
Rosiglitazone alleviates intrahepatic cholestasis induced by α-naphthylisothiocyanate in mice: The role of circulating 15-deoxy-Δ
Topics: 1-Naphthylisothiocyanate; Animals; Cholestasis, Intrahepatic; Humans; Mice; PPAR gamma; Prostaglandin D2; Rosiglitazone | 2020 |
Effect of thiazolidinediones on bile acid transport in rat liver.
Topics: Animals; Bile Acids and Salts; Bile Canaliculi; Biological Transport; Cell Membrane; Cholestasis, Intrahepatic; Chromans; Dose-Response Relationship, Drug; Hypoglycemic Agents; Liver; Male; Rats; Rats, Sprague-Dawley; Rosiglitazone; Thiazolidinediones; Transport Vesicles; Troglitazone | 2007 |